Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Occipital Nerve Stimulation in Trigeminal Autonomic Cephalalgias: A Double-blind, Phase II, Randomized, Controlled Trial

NCT04937010 is registered in ClinicalTrials.gov with Alberta Health Services, Calgary as lead sponsor.

NCT NCT04937010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Occipital Nerve Stimulation in Trigeminal Autonomic Cephalalgias: A Double-blind, Phase II, Randomized, Controlled Trial
Lead sponsor
Alberta Health Services, Calgary
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2022
Completion date
September 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trigeminal autonomic cephalgia